2009•LeukemiaRequires access

Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR/ABL-positive ALL: implications for residual disease monitoring

Markéta Žaliová, Eva Froňková, Kateřina Krejčíková, K Muzikova, Ester Mejstříková, Jan Starý, Jan Trka, Jan Zuna

Open publisher page 50 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 50 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Minimal residual disease, T-cell receptor, breakpoint cluster region, Fusion gene, ABL, Biology, Bone marrow, Oncology

Back to paper search Browse research topics Original source

Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR/ABL-positive ALL: implications for residual disease monitoring — Research Paper | ScholarLens